Drug profile · INN
diltiazem hydrochloride
DILACOR XR
diltiazem hydrochloride (DILACOR XR) is a voltage-gated l-type calcium channel blocker. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Drug details — diltiazem hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
diltiazem hydrochloride (DILACOR XR) is a voltage-gated l-type calcium channel blocker. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Voltage-gated L-type calcium channel blocker
Primary target: Voltage-gated L-type calcium channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is diltiazem hydrochloride?
diltiazem hydrochloride (DILACOR XR) is a voltage-gated l-type calcium channel blocker. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for diltiazem hydrochloride?
DILACOR XR is a marketed brand name for diltiazem hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of diltiazem hydrochloride?
diltiazem hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.